All Type of News
Lee to become head of Korea Human Resource Development Institute
Lee Sang-yong, an incumbent deputy chief of the Korea Food and Drug Administration, is likely to replace Lee Sang-seok at the end of this month, according to pharmaceutical sources.
Lee, who were appointed at the i...
How will NHIC cope with drug medication redemption lawsuit?
Seoul Central District Court will make its final ruling on redemption suit of medication costs against Yungjin Pharm and Ildong Pharm on October 14, marking the beginning of a lawsuit that could potentially force the ...
Samyang Genex to gear up export for European market
Samyang Genex said it has recently signed an agreement with an European multinational firm to supply its anticancer drug “Genexol“ (paclitaxel), paving a way to make inroad into an European market.
This agreement w...
Viromed, Eureka to conduct joint research over antibody cancer drug
ViroMed Co., a local biopharmaceutical company, says it has signed a memorandum of understanding with the US based Eureka Therapeutics Inc. to accelerate the development of antibody cancer drugs, such as Swiss Drug Gi...
KPMA to look into drug makers
The Korea Pharmaceutical Manufacturers Association (KPMA), a local pharmaceutical business lobby group, has embarked on looking into eight drug makers’ undue business practices such as rebate-offering, according to a ...
KIPO publishes evergreen patent report
The Korean Intellectual Property Office said that it has recently published a report titled “Evergreen patent strategies and patent dispute cases” to help local pharmaceutical companies develop more competitive drugs ...
Drug agency grilled over Tamiflu shelf-life extension
An opposition party lawmaker raised suspicions on the nation’s drug agency decision to extend the shelf life of the flu drug Tamiflu by two years, , during the parliamentary audit to the Korea Food and Drug Administra...
Oscotec discovers bone growth compound
Oscotec Inc., a bone specialized biotech company based in Korea, says it has discovered a promising drug candidate to facilitate the bone growth under a two-year joint research with Harvard Medical School’s Institute ...
Ildong witnesses impressive multivitamin sales
Ildong Pharm said its multivitamin Aronami-C Plus garnered 11.5 billion won in sales in the January-September period, thanks much to big popularity in all age groups.
The company forecast its sales will exceed 14.5...
Zuellig criticized for unfair business practice
Zuellig Korea is under fire for having allegedly instigated pharmacies in Daegu and North Kyungbuk Province to stop dealing with Dongwon Pharm, amid the situation where three associate wholesalers has recently severed...
